AstraZeneca PLC - Days of Sales Outstanding
AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in Days.
The item "Days-of-Sales-Outstanding" stands at 87.63 days as of 09/30/2025.
As of the end of AstraZeneca PLC's third quarter, the item "Days of Sales Outstanding" stands at 87.63 Days. This represents a decrease of -0.65 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.8875 percent compared to the value the year prior.
The 1 year change in percent is -0.8875.
The 3 year change in percent is 13.19.
The Serie's change in percent from it's minimum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is +17.75%.
The Serie's change in percent from it's maximum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is -5.12%.
Days of Sales Outstanding for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Days of Sales Outstanding | 905,699,262,464.00 |
 | Johnson & Johnson - Days of Sales Outstanding | 486,508,953,600.00 |
 | AbbVie Inc - Days of Sales Outstanding | 399,570,305,024.00 |
 | Roche Holding AG - Days of Sales Outstanding | 317,433,206,677.55 |
 | Novartis AG - Days of Sales Outstanding | 255,096,620,580.91 |